ARCHIVES

FDA Breakthrough Designation Granted to Pfizer’s Palbociclib

This article is from The Cancer Letter archive.

Vol. 36 No. 4 | April 26, 2013

Download PDF Visit The Full Archive

Related Articles

Some Of Show’s Screening Messages Not Widely Accepted.

September 12, 2008

ORI Withdraws Requirement For Research Ethics Courses.

February 23, 2001

New Agents, New Approaches Benefit Treatment Of Advanced Lung Cancer

August 29, 2003

ACCC Seeking Line Item, $21 Million for CCPs; Results Of Evaluation Released

June 5, 1987

Committee Drafts QRA Definition

November 19, 1982

NCI Drops Two CCOPS, Cincinnati And West Virginia, For Lack Of Patient Entry; 60 Funded Another Year

August 24, 1984